Literature DB >> 11423739

Fertility after bilateral cryptorchidism. Evaluation by paternity, hormone, and semen data.

P A Lee1, M T Coughlin.   

Abstract

PURPOSE: Evaluation of the fertility of a cohort of formerly bilaterally cryptorchid men in comparison with a group of formerly unilaterally cryptorchid men, and a group of control men.
MATERIALS AND METHODS: Using a detailed questionnaire concerning paternity and factors related to paternity, a cohort of formerly bilateral cryptorchid men were studied and compared with men who had undergone orchiopexy for unilateral cryptorchidism, and a group of control men. All study subjects had had surgery at the Children's Hospital of Pittsburgh, Pittsburgh, Pa., between 1955 and 1975. A subset of the full cohort underwent clinical evaluation that included a physical examination, serum hormonal determination and semen analyses.
RESULTS: Paternity rates are significantly lower among the formerly bilaterally cryptorchid men who have attempted to father a child (65.3%) as compared to the formerly unilaterally cryptorchid (89.7%; p < 0.001) and control men (93.2%; p < 0.001). Differences in the ability to father children are also apparent when semen and hormone levels are compared between the three groups. The bilateral group has significantly lower sperm density and inhibin B levels, and higher FSH and LH levels, than the unilateral and control groups.
CONCLUSIONS: Men born with bilateral cryptorchidism have severely compromised fertility in adulthood. This reduction in fertility is clearly shown in comparisons of both paternity rates, and in semen and hormone analyses, between the formerly bilateral, formerly unilateral, and control groups. Copyright 2001 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11423739     DOI: 10.1159/000049960

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  35 in total

1.  Patterns of referral and treatment of undescended testis: a 12-year experience in a single centre.

Authors:  T Golabek; E Kiely
Journal:  Ir J Med Sci       Date:  2010-08-19       Impact factor: 1.568

2.  Genomic and genetic variation in E2F transcription factor-1 in men with nonobstructive azoospermia.

Authors:  Carolina J Jorgez; Nathan Wilken; Josephine B Addai; Justin Newberg; Hima V Vangapandu; Alexander W Pastuszak; Sarmistha Mukherjee; Jill A Rosenfeld; Larry I Lipshultz; Dolores J Lamb
Journal:  Fertil Steril       Date:  2014-10-24       Impact factor: 7.329

3.  A risk assessment of a common drug using xenograft model.

Authors:  Masami Kodama; Junko Kurokawa
Journal:  Ann Transl Med       Date:  2017-02

4.  Cryptorchidism and its impact on male fertility: a state of art review of current literature.

Authors:  Eric Chung; Gerald B Brock
Journal:  Can Urol Assoc J       Date:  2011-06       Impact factor: 1.862

5.  Delayed treatment of undescended testes may promote hypogonadism and infertility.

Authors:  Julia Rohayem; Alessandra Luberto; Eberhard Nieschlag; Michael Zitzmann; Sabine Kliesch
Journal:  Endocrine       Date:  2017-01-09       Impact factor: 3.633

6.  [Cryptorchidism and infertility from the perspective of interdisciplinary guidelines].

Authors:  M J Mathers; S Degener; S Roth
Journal:  Urologe A       Date:  2011-01       Impact factor: 0.639

7.  [Undescended testis: aspects of treatment].

Authors:  I Körner; H Rübben
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

8.  Current Management of Undescended Testes.

Authors:  David Kurz
Journal:  Curr Treat Options Pediatr       Date:  2016-01-25

9.  Protective effect of α-tocopherol on damage to rat testes by experimental cryptorchidism.

Authors:  Rosa María Vigueras-Villaseñor; Idahue Ojeda; Oscar Gutierrez-Pérez; Margarita Chavez-Saldaña; Osvaldo Cuevas; Daniel Santa Maria; Julio César Rojas-Castañeda
Journal:  Int J Exp Pathol       Date:  2011-02-12       Impact factor: 1.925

Review 10.  Fertility potential after unilateral and bilateral orchidopexy for cryptorchidism.

Authors:  Bojan Trsinar; Ursula Res Muravec
Journal:  World J Urol       Date:  2009-04-08       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.